EMPAA M 12.5/500MG TABLET

Empaa M 12.5/500mg tablet is a combination medication that contains two active ingredients: Empagliflozin and Metformin. Empagliflozin belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which help lower blood sugar levels by preventing the reabsorption of glucose in the kidneys and promoting its excretion through urine. Metformin is a medication that reduces glucose production in the liver and improves the body’s response to insulin.

This combination medication is commonly prescribed for the management of type 2 diabetes mellitus in adults. It helps control blood sugar levels by multiple mechanisms, including reducing glucose absorption from the kidneys and improving insulin sensitivity.

Side Effects:

1. Common side effects of Empaa M 12.5/500mg tablet may include:
   • Urinary tract infections
   • Increased urination
   • Thirst or dry mouth
   • Upset stomach or diarrhea
   • Nausea or vomiting
   • Abdominal pain or discomfort
   • Headache
   • Hypoglycemia (low blood sugar) when used in combination with certain other medications that can lower blood sugar
2. Rare but serious side effects that require immediate medical attention include:
   • Allergic reactions (rash, itching, swelling of the face, lips, or throat)
   • Dehydration or signs of electrolyte imbalance (excessive thirst, dry mouth, weakness, dizziness)
   • Severe stomach pain
   • Severe or persistent diarrhea
   • Lactic acidosis (a buildup of lactic acid in the body) characterized by symptoms like weakness, unusual muscle pain, difficulty breathing, stomach pain with nausea and vomiting

If any severe or persistent side effects occur, it is important to seek medical assistance promptly.

When Not to Use:

Empaa M 12.5/500mg tablet should not be used under the following conditions:

1. Allergy: Do not take this medication if you have a known allergy or hypersensitivity to Empagliflozin, Metformin, or any of the other ingredients present in the tablet.
2. Severe Kidney Disease or Impairment: This medication is not recommended for individuals with severe kidney disease or impaired kidney function, as it may further compromise kidney function.
3. Diabetic Ketoacidosis: Empaa M tablets should not be used in cases of diabetic ketoacidosis, a serious complication of diabetes characterized by high blood sugar, ketones in the urine, and acidosis.
4. Liver Disease: Individuals with severe liver disease or abnormal liver function should avoid using this medication.
5. Heart Failure: This medication may not be suitable for individuals with severe heart failure or a history of heart failure.

It is essential to consult a healthcare professional before starting or stopping any medication to ensure it is appropriate for your specific medical condition and to discuss any potential drug interactions or contraindications.